Skip to content
Loop Biz – Lifestyle
Author:
CO-DIAGNOSTICS
Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer
July 16, 2026
Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand
July 8, 2026
Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test
July 1, 2026
Co-Diagnostics Vector Smart® Division Expands Footprint to 21 States
June 25, 2026
Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line
June 18, 2026
Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement
June 11, 2026
Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities
June 2, 2026
Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara
May 26, 2026
Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
May 19, 2026
Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
May 19, 2026
1
2
3
Next Page
→